Cochlear's hearing big profit growth | Manchester United rejects Qatari takeover bid | Pfizer's vaccine decline

Cochlear, the ASX-listed bionic ear company, reckons its profit to grow by double digits in this financial year. A major bid to buy Manchester United football club has failed because its majority owners just weren’t happy with the price tag. Pfizer has announced that it will cut over $9 billion USD from its annual sales forecast after declining demand for Covid vaccines…and investors are kind of here for it. — We want your feedback - win 3 x $100 Uber Eats vouchers for your thoughts: https://fluxsurvey.typeform.com/to/qxN2pL4c Build the financial wellbeing of your team with Flux at Work: https://bit.ly/fluxatwork Download the free app (App Store): http://bit.ly/FluxAppStore Download the free app (Google Play): http://bit.ly/FluxappGooglePlay Daily newsletter: https://bit.ly/fluxnewsletter Flux on Instagram: http://bit.ly/fluxinsta Flux on TikTok: https://www.tiktok.com/@flux.finance —- The content in this podcast reflects the views and opinions of the hosts, and is intended for personal and not commercial use. We do not represent or endorse the accuracy or reliability of any opinion, statement or other information provided or distributed in these episodes.See omnystudio.com/listener for privacy information.